An assessment of the effects of ectopic gp91phox expression in XCGD iPSC-derived neutrophils

Molecular Therapy Methods and Clinical Development

Volumn 2, Issue , 2015, Pages 15046-

  Lin, Huan Ting ^a   Masaki, Hideki ^b   Yamaguchi, Tomoyuki ^a,b   Wada, Taizo ^c   Yachie, Akihiro ^c   Nishimura, Ken ^d,e   Ohtaka, Manami ^d   Nakanishi, Mahito ^d   Nakauchi, Hiromitsu ^a,b   Otsu, Makoto ^a  

^a THE UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^d NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^e UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; COMPLEMENTARY DNA; LIPOCORTIN 5; MYELOPEROXIDASE; NERVE GROWTH FACTOR RECEPTOR; PUROMYCIN; RETROVIRUS VECTOR; STAGE SPECIFIC EMBRYO ANTIGEN 4;

APOPTOSIS ASSAY; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL MATURATION; CELL VIABILITY; CHRONIC GRANULOMATOUS DISEASE; CODON; COMPARATIVE STUDY; CONTROLLED STUDY; ECTOPIC EXPRESSION; ENZYME ACTIVITY; EXTRACELLULAR TRAP; FLOW CYTOMETRY; GENETIC BACKGROUND; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; INDUCED PLURIPOTENT STEM CELL; NEUTROPHIL; PHENOTYPE; PLURIPOTENT STEM CELL; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; X CHROMOSOME LINKED DISORDER; X LINKED CHRONIC GRANULOMATOUS DISEASE; 7-AAD ASSAY; CELL GRANULE; CELL PROTECTION; EMBRYONIC STEM CELL; GENETIC TRANSDUCTION; NONHUMAN; SENDAI VIRUS;

EID: 85015209663     PISSN: None     EISSN: 23290501     Source Type: Journal    
DOI: 10.1038/mtm.2015.46     Document Type: Article

References (43)

1. 1 Segal, AW, The NADPH oxidase and chronic granulomatous disease. Mol Med Today 2 (1996), 129–135.
2. 2 Segal, BH, Leto, TL, Gallin, JI, Malech, HL, Holland, SM, Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 79 (2000), 170–200.
3. 3 Segal, BH, Veys, P, Malech, H, Cowan, MJ, Chronic granulomatous disease: lessons from a rare disorder. Biol Blood Marrow Transplant 17(suppl. 1) (2011), S123–S131.
4. 4 Candotti, F, Shaw, KL, Muul, L, Carbonaro, D, Sokolic, R, Choi, C, et al. Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans. Blood 120 (2012), 3635–3646.
5. 5 Cavazzana-Calvo, M, Hacein-Bey, S, de Saint Basile, G, Gross, F, Yvon, E, Nusbaum, P, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288 (2000), 669–672.
6. 6 Scaramuzza, S, Biasco, L, Ripamonti, A, Castiello, MC, Loperfido, M, Draghici, E, et al. Preclinical safety and efficacy of human CD34(+) cells transduced with lentiviral vector for the treatment of Wiskott-Aldrich syndrome. Mol Ther 21 (2013), 175–184.
7. 7 Malech, HL, Choi, U, Brenner, S, Progress toward effective gene therapy for chronic granulomatous disease. Jpn J Infect Dis 57 (2004), S27–S28.
8. 8 Bianchi, M, Hakkim, A, Brinkmann, V, Siler, U, Seger, RA, Zychlinsky, A, et al. Restoration of NET formation by gene therapy in CGD controls aspergillosis. Blood 114 (2009), 2619–2622.
9. 9 Stein, S, Ott, MG, Schultze-Strasser, S, Jauch, A, Burwinkel, B, Kinner, A, et al. Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat Med 16 (2010), 198–204.
10. 10 Chen, C, Liu, Y, Liu, R, Ikenoue, T, Guan, KL, Liu, Y, et al. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J Exp Med 205 (2008), 2397–2408.
11. 11 Zhen, L, Yu, L, Dinauer, MC, Probing the role of the carboxyl terminus of the gp91phox subunit of neutrophil flavocytochrome b558 using site-directed mutagenesis. J Biol Chem 273 (1998), 6575–6581.
12. 12 Bedard, K, Krause, KH, The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87 (2007), 245–313.
13. 13 Kuwabara, WM, Zhang, L, Schuiki, I, Curi, R, Volchuk, A, Alba-Loureiro, TC, NADPH oxidase-dependent production of reactive oxygen species induces endoplasmatic reticulum stress in neutrophil-like HL60 cells. PLoS One, 10, 2015, e0116410.
14. 14 Li, G, Scull, C, Ozcan, L, Tabas, I, NADPH oxidase links endoplasmic reticulum stress, oxidative stress, and PKR activation to induce apoptosis. J Cell Biol 191 (2010), 1113–1125.
15. 15 Takahashi, K, Tanabe, K, Ohnuki, M, Narita, M, Ichisaka, T, Tomoda, K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007), 861–872.
16. 16 Zou, J, Sweeney, CL, Chou, BK, Choi, U, Pan, J, Wang, H, et al. Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting. Blood 117 (2011), 5561–5572.
17. 17 Jiang, Y, Cowley, SA, Siler, U, Melguizo, D, Tilgner, K, Browne, C, et al. Derivation and functional analysis of patient-specific induced pluripotent stem cells as an in vitro model of chronic granulomatous disease. Stem Cells 30 (2012), 599–611.
18. 18 Yokoyama, Y, Suzuki, T, Sakata-Yanagimoto, M, Kumano, K, Higashi, K, Takato, T, et al. Derivation of functional mature neutrophils from human embryonic stem cells. Blood 113 (2009), 6584–6592.
19. 19 Brinkmann, V, Reichard, U, Goosmann, C, Fauler, B, Uhlemann, Y, Weiss, DS, et al. Neutrophil extracellular traps kill bacteria. Science 303 (2004), 1532–1535.
20. 20 Metzler, KD, Fuchs, TA, Nauseef, WM, Reumaux, D, Roesler, J, Schulze, I, et al. Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity. Blood 117 (2011), 953–959.
21. 21 Zhang, XB, Cellular reprogramming of human peripheral blood cells. Genomics Proteomics Bioinformatics 11 (2013), 264–274.
22. 22 Pfaff, N, Lachmann, N, Ackermann, M, Kohlscheen, S, Brendel, C, Maetzig, T, et al. A ubiquitous chromatin opening element prevents transgene silencing in pluripotent stem cells and their differentiated progeny. Stem Cells 31 (2013), 488–499.
23. 23 Kaufmann, KB, Brendel, C, Suerth, JD, Mueller-Kuller, U, Chen-Wichmann, L, Schwäble, J, et al. Alpharetroviral vector-mediated gene therapy for X-CGD: functional correction and lack of aberrant splicing. Mol Ther 21 (2013), 648–661.
24. 24 Herbst, F, Ball, CR, Tuorto, F, Nowrouzi, A, Wang, W, Zavidij, O, et al. Extensive methylation of promoter sequences silences lentiviral transgene expression during stem cell differentiation in vivo. Mol Ther 20 (2012), 1014–1021.
25. 25 Hasegawa, K, Cowan, AB, Nakatsuji, N, Suemori, H, Efficient multicistronic expression of a transgene in human embryonic stem cells. Stem Cells 25 (2007), 1707–1712.
26. 26 Yoshida, LS, Saruta, F, Yoshikawa, K, Tatsuzawa, O, Tsunawaki, S, Mutation at histidine 338 of gp91(phox) depletes FAD and affects expression of cytochrome b558 of the human NADPH oxidase. J Biol Chem 273 (1998), 27879–27886.
27. 27 Kobayashi, SD, Voyich, JM, Braughton, KR, Whitney, AR, Nauseef, WM, Malech, HL, et al. Gene expression profiling provides insight into the pathophysiology of chronic granulomatous disease. J Immunol 172 (2004), 636–643.
28. 28 Kim, SY, Jun, HS, Mead, PA, Mansfield, BC, Chou, JY, Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type Ib. Blood 111 (2008), 5704–5711.
29. 29 Grez, M, Reichenbach, J, Schwäble, J, Seger, R, Dinauer, MC, Thrasher, AJ, Gene therapy of chronic granulomatous disease: the engraftment dilemma. Mol Ther 19 (2011), 28–35.
30. 30 Wu, C, Dunbar, CE, Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity. Front Med 5 (2011), 356–371.
31. 31 Chiriaco, M, Farinelli, G, Capo, V, Zonari, E, Scaramuzza, S, Di Matteo, G, et al. Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosis. Mol Ther 22 (2014), 1472–1483.
32. 32 Dodd, S, Dean, O, Copolov, DL, Malhi, GS, Berk, M, N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility. Expert Opin Biol Ther 8 (2008), 1955–1962.
33. 33 Nishimura, K, Sano, M, Ohtaka, M, Furuta, B, Umemura, Y, Nakajima, Y, et al. Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming. J Biol Chem 286 (2011), 4760–4771.
34. 34 Suerth, JD, Maetzig, T, Galla, M, Baum, C, Schambach, A, Self-inactivating alpharetroviral vectors with a split-packaging design. J Virol 84 (2010), 6626–6635.
35. 35 Suerth, JD, Maetzig, T, Brugman, MH, Heinz, N, Appelt, JU, Kaufmann, KB, et al. Alpharetroviral self-inactivating vectors: long-term transgene expression in murine hematopoietic cells and low genotoxicity. Mol Ther 20 (2012), 1022–1032.
36. 36 Shibuya, K, Shirakawa, J, Kameyama, T, Honda, S, Tahara-Hanaoka, S, Miyamoto, A, et al. CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation. J Exp Med 198 (2003), 1829–1839.
37. 37 Bonini, C, Ferrari, G, Verzeletti, S, Servida, P, Zappone, E, Ruggieri, L, et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 276 (1997), 1719–1724.
38. 38 Yamaguchi, T, Hamanaka, S, Kamiya, A, Okabe, M, Kawarai, M, Wakiyama, Y, et al. Development of an all-in-one inducible lentiviral vector for gene specific analysis of reprogramming. PLoS One, 7, 2012, e41007.
39. 39 Takayama, N, Nishimura, S, Nakamura, S, Shimizu, T, Ohnishi, R, Endo, H, et al. Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J Exp Med 207 (2010), 2817–2830.
40. 40 Masaki, H, Ishikawa, T, Takahashi, S, Okumura, M, Sakai, N, Haga, M, et al. Heterogeneity of pluripotent marker gene expression in colonies generated in human iPS cell induction culture. Stem Cell Res 1 (2007), 105–115.
41. 41 Takayama, N, Nishikii, H, Usui, J, Tsukui, H, Sawaguchi, A, Hiroyama, T, et al. Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors. Blood 111 (2008), 5298–5306.
42. 42 Brinkmann, V, Laube, B, Abu Abed, U, Goosmann, C, Zychlinsky, A, Neutrophil extracellular traps: how to generate and visualize them. J Vis Exp, 36, 2010, e1724.
43. 43 Vowells, SJ, Sekhsaria, S, Malech, HL, Shalit, M, Fleisher, TA, Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods 178 (1995), 89–97.